Work

Pre-Transplant 5-Azacitidine (Vidaza®) May Improve Outcome of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Myelodysplastic Syndrome (MDS).

Year: 2006

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v108.11.3664.3664

Authors: Teresa Field, Janelle Perkins, Melissa Alsina, Ernesto Ayala, Hugo F. Fernandez, William Janssen, Mohamed Kharfan-Dabaja, Jeffery Lancet, Lia Perez, Daniel Sullivan, Alan List, Claudio Anasetti

Institution: Moffitt Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2580835465

FWCI: 1.002

Cites:

Cited by: 7

Related to: 10